购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • APC/C
    (1)
  • Apoptosis
    (1)
  • PKA
    (1)
  • Others
    (6)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (2)
  • 5日内发货
    (64)
  • 20日内发货
    (2)
  • 35日内发货
    (1)
筛选
搜索结果
TargetMol产品目录中 "

apc 2

"的结果
  • 抑制剂&激动剂
    8
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    5
    TargetMol | Recombinant_Protein
  • 检测抗体
    61
    TargetMol | Antibody_Products
  • AP-C2
    T77570682793-07-3
    AP-C2 是一种有效的小分子鸟苷 3',5'-环单磷酸 (cGMP) 依赖性蛋白激酶 II (cGKII) 抑制剂,对 cGKII 的 pIC50 为 5.2。
    • ¥ 235
    现货
    规格
    数量
    TargetMol | Inhibitor Sale
  • CFM 4
    CFM-4, CFM4
    T22646331458-02-7
    CFM 4 是一种有效的小分子 CARP-1 APC-2 拮抗剂,阻止 CARP-1 与 APC-2 结合,促使 G2M 细胞周期阻滞,引起细胞凋亡,其 IC50 范围为 10-15 μM。CFM 4 对耐药人类乳腺癌细胞的生长有抑制作用。
    • ¥ 348
    现货
    规格
    数量
    TargetMol | Inhibitor Sale
  • CFM-1
    CFM1, CFM 1
    T238751380448-60-1
    CFM-1 is an antagonist of the anaphase-promoting complex (APC)-2. It also is a cell cycle and apoptosis regulatory protein (CARP)-1 interaction antagonist.
    • ¥ 10600
    6-8周
    规格
    数量
  • CRA-2059 hydrochloride
    T38051
    CRA-2059 hydrochloride is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2]. Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell secretory granules. CRA-2059 hydrochloride has the potential for inflammatory bowel disease research[1]. [1]. Tremaine WJ, et al. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Pharmacol Ther. 2002;16(3):407-413.[2]. Selwood T, et al. Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor. Biol Chem. 2003;384(12):1605-1611.
    • ¥ 3045
    期货
    规格
    数量
  • APC 366
    T22189158921-85-8
    APC 366 是肥大细胞类胰蛋白酶 (tryptase) 的选择性抑制剂,Ki 值为7.1 μM。在羊过敏性哮喘模型中,APC 366 抑制抗原诱导的早期哮喘反应 (EAR)、晚期哮喘反应 (LAR) 和支气管高反应性 (BHR)。
    • 待估
    35日内发货
    规格
    数量
  • CRA-2059 TFA
    T38052
    CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2]. Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell secretory granules. CRA-2059 has the potential for inflammatory bowel disease research[1]. [1]. Tremaine WJ, et al. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Pharmacol Ther. 2002;16(3):407-413.[2]. Selwood T, et al. Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor. Biol Chem. 2003;384(12):1605-1611.
    • ¥ 3045
    期货
    规格
    数量
  • Drotrecogin alfa (activated)
    T8252698530-76-8
    Drotrecogin alfa activated (DrotAA)为重组人活化蛋白C(APC)。该化合物能够抑制由烟雾引起的大鼠肺微血管通透性上升及促炎细胞因子IL-1β水平增加,具有抗凝血与抗炎作用,并促进纤溶过程。Drotrecogin alfa activated主要用于重症脓毒症的实验研究。
    • 待询
    规格
    数量
  • ONO-1714 HCl
    ONO-1714 hydrochloride, ONO-1714, ONO1714, ONO 1714
    T28247214479-33-1
    ONO-1714 is a inducible nitric oxide synthase (NOS-2) inhibitor. ONO-1714 reduces hyperoxic lung injury in mice. ONO-1714 attenuates inflammation-related large bowel carcinogenesis in male Apc(Min +) mice. ONO-1714 also inhibits neuronal NOS and exerts an
    • ¥ 10600
    期货
    规格
    数量
没有更多数据了